System and method for detection of pulmonary embolism

Patent metadata

Field	Value
Publication number	US-9750416-B2
Application number	US-201213438682-A
Country	US
Kind code	B2
Filing date	Apr 3, 2012
Priority date	May 7, 2008
Publication date	Sep 5, 2017
Grant date	Sep 5, 2017

Abstract

Systems and methods provide for ambulatorily sensing pulmonary artery pressure from within a patient, and producing a pulmonary artery pressure measurement from the sensed pulmonary artery pressure. Power is ambulatorily provided within the patient to facilitate sensing of the pulmonary artery pressure and producing of the pulmonary artery pressure measurement. Acute pulmonary embolism is detected based on a change or rate of change in the pulmonary artery pressure measurement. An alert is preferably generated in response to detecting pulmonary embolism.

First claim

What is claimed is:

1. A method, comprising:
ambulatorily sensing pulmonary artery pressure from within a pulmonary artery of a patient;
ambulatorily sensing, using at least one electrode disposed external to the patient, a first cardiac electrical signal of the patient;
producing a pulmonary artery pressure measurement from the sensed pulmonary artery pressure and producing a pulmonary artery pressure waveform indicative of the sensed pulmonary artery pressure, wherein timing of the pulmonary artery pressure measurement is based at least in part on the sensed cardiac electrical signal;
ambulatorily providing power within the patient by at least one of subcutaneously providing power and transcutaneously providing power to facilitate the sensing of the pulmonary artery pressure and the cardiac electrical signal, and the producing of the pulmonary artery pressure measurement;
detecting acute pulmonary embolism based on a change in a morphological feature of the pulmonary artery pressure waveform;
ambulatorily sensing, using the at least one electrode, at least one of the first cardiac electrical signal and a second cardiac electrical signal of the patient; and
verifying detection of the acute pulmonary embolism using the at least one of the first cardiac electrical signal and the second cardiac electrical signal.

2. The method of claim 1 , wherein detecting acute pulmonary embolism comprises detecting acute pulmonary embolism based on the change in the morphological feature relative to a threshold, the threshold comprising a baseline of the morphological feature established for the patient.

3. The method of claim 1 , wherein detecting acute pulmonary embolism comprises detecting acute pulmonary embolism based on the change in the morphological feature relative to a threshold, the threshold comprising a baseline pulmonary artery pressure value determined for the patient using patient specific data.

4. The method of claim 1 , wherein verifying detection of the acute pulmonary embolism includes matching the at least one of the first cardiac electrical signal and the second cardiac electrical signal to a template that is indicative of a pattern that indicates presence of the acute pulmonary embolism.

5. The method of claim 4 , wherein the pattern comprises an S1Q3T3 pattern.

6. The method of claim 1 , further comprising discriminating between acute pulmonary embolism and myocardial infarction based on a change of the pulmonary artery pressure measurement relative to a change in a feature of the sensed cardiac electrical signal.

7. The method of claim 6 , wherein the feature of the sensed cardiac electrical signal comprises an ST segment of the sensed cardiac electrical signal, and discriminating between acute pulmonary embolism and myocardial infarction comprises:
detecting myocardial infarction as a change in a feature of the ST segment; and
detecting acute pulmonary embolism as a change in the pulmonary artery pressure measurement in the absence of an appreciable change in the ST segment feature or other myocardial infarction-associated feature of the sensed cardiac electrical signal.

8. The method of claim 1 , further comprising discriminating between acute pulmonary embolism and primary pulmonary hypertension based on a rate of change of the pulmonary artery pressure measurement.

9. The method of claim 1 , further comprising:
sensing a parameter indicative of heart failure from within the patient; and
discriminating between acute pulmonary embolism and heart failure induced pulmonary hypertension based on a rate of change of the pulmonary artery pressure measurement and a change in the sensed parameter.

10. The method of claim 1 , further comprising discriminating between chronic pulmonary embolism and primary pulmonary hypertension based on one or more of a fractional pulse pulmonary artery pressure derived from a waveform indicative of the sensed pulmonary artery pressure, a coefficient of variation of the pulmonary artery pressure derived from the pulmonary artery pressure waveform, and a fractional time to half the area under the pulmonary artery pressure waveform.

11. A system, comprising:
an implantable pressure sensor configured to ambulatorily sense pulmonary artery pressure from within a patient, the pressure sensor comprising:
a support structure comprising a stabilizing arrangement configured to stabilize the pressure sensor within a pulmonary artery of the patient;
a pressure transducer;
a communications device coupled to the pressure transducer, the communications device configured to effect wireless transmission of a pulmonary artery pressure waveform out of the patient's heart, the pressure transducer and the communications device supported by the support structure; and
an energy source configured to supply power for the pressure transducer and the communications device;

an external cardiac electrical activity sensor configured to sense, using at least one electrode disposed external to the patient, cardiac electrical activity and output a cardiac electrical signal; and
a processor communicatively coupled to the communications device of the pressure sensor and to the external cardiac electrical activity sensor, the processor configured to execute programmed instructions for making a pulmonary artery pressure measurement based at least in part on the cardiac electrical signal and detecting acute pulmonary embolism based on a change in a morphological feature of the pulmonary artery pressure waveform and verifying detection of the acute pulmonary embolism using the cardiac electrical signal.

12. The system of claim 11 , comprising a portable patient-external system disposed in a housing configured for hand-held manipulation and a patient-external server system, the housing of the portable patient-external system comprising communications circuitry configured to effect wireless communications with the communications device of the pressure sensor and communications with the patient-external server system, the processor disposed in at least one of the housing of the portable patient-external system and the patient-external server system.

13. The system of claim 11 , wherein the implantable pressure sensor comprises a charging circuit responsive to an acoustic or inductive signal, the charging circuit generating energy for powering the pressure sensor in response to the acoustic or inductive signal.

14. The system of claim 11 , wherein the support structure of the pressure sensor comprises a stent graft configured to radially contract during implantation in the pulmonary artery and expand to stabilize the pressure sensor at an implant site within the pulmonary artery.

15. The system of claim 11 , wherein the communications device coupled to the pressure sensor comprises an acoustic communications device.

16. The system of claim 11 , wherein the processor is configured to execute programmed instructions for discriminating between acute pulmonary embolism and myocardial infarction based on a change of the pulmonary artery pressure waveform relative to a change in a feature of the cardiac electrical signal.

17. The system of claim 16 , wherein the feature of the cardiac electrical signal comprises a feature of an ST segment of the cardiac electrical signal, wherein the processor is configured to execute programmed instructions for detecting myocardial infarction as a change in the ST segment feature and for detecting acute pulmonary embolism as a change in the pulmonary artery pressure measurement in the absence of an appreciable change in the ST segment feature

Assignees

• Liao Wangcai
• Stahmann Jeffrey
• Mi Bin
• Zhang Yunlong
• Cardiac Pacemakers Inc

Inventors

• Liao Wangcai
• Stahmann Jeffrey
• Mi Bin
• Zhang Yunlong

Classifications

• A61B5/7275

  Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor · CPC title

• A61B5/412

  Detecting or monitoring sepsis · CPC title

• A61B5/02108

  from analysis of pulse wave characteristics · CPC title

• A61B5/08

  Measuring devices for evaluating the respiratory organs · CPC title

• A61B5/6846

  specially adapted to be brought in contact with an internal body part, i.e. invasive · CPC title